Profile data is unavailable for this security.
About the company
Sotac Pharmaceuticals Limited is an India-based company. The Company is a is pharma manufacturer, specializing in manufacturing of a wide range of pharmaceutical products, such as Non Beta-Lactam (general) tablets, Non Beta-Lactam (general) capsules, Non Beta-lactam Syrup and external preparations. The Company is engaged in the business of manufacturing of pharmaceutical products for different marketers on loan license or contract manufacturing basis. The Company’s therapeutic portfolio includes Anti-Diabetic, Anti-Psychotic, Vitamins, Minerals, Iron, Anti-Cold, AntiAllergic, Derma Products, Antacid, Anti-Ulcerants, PPI, Anti-Emetics, Cardiac, Anti-Hypertensives, Analgesic, AntiPyretic, Anti-Inflammatory, Anti-Bacterial, Anti-Viral, General Antibiotics IP-Lactams and Non-IP-Lactams, Anti-Fungal, Cephalosporin. Its pharmaceutical manufacturing facilities are situated at Sanand GIDC-II in Ahmedabad district of Gujarat.
- Revenue in INR (TTM)579.83m
- Net income in INR44.96m
- Incorporated2015
- Employees89.00
- LocationSotac Pharmaceuticals LtdAHMEDABAD 382110IndiaIND
- Websitehttps://sotacpharma.com/contact-us/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biofil Chemicals and Pharmaceuticals Ltd | 384.48m | 6.69m | 1.13bn | -- | 168.64 | -- | 102.80 | 2.94 | 0.4118 | 0.4118 | 23.91 | -- | -- | -- | -- | -- | -- | 2.86 | -- | 5.39 | 6.82 | 11.61 | 1.74 | 2.97 | -- | 27.03 | -- | -- | 34.19 | 19.43 | -19.76 | 3.55 | -51.09 | -- |
| Ind Swift Ltd | 5.02bn | 142.31m | 1.15bn | 1.67k | 8.06 | -- | 2.78 | 0.2286 | 2.63 | 2.63 | 92.94 | -127.54 | 0.7705 | 3.66 | 3.91 | -- | 2.18 | -0.902 | 60.58 | -- | 44.02 | 45.72 | 2.83 | -1.44 | 0.8668 | 0.3401 | 3.14 | -- | 22.21 | 11.68 | -45.34 | 11.68 | 15.24 | -- |
| Lasa Supergenerics Ltd | 1.17bn | -214.42m | 1.17bn | 89.00 | -- | -- | -- | 1.00 | -4.28 | -4.28 | 23.30 | -- | -- | -- | -- | 13,128,270.00 | -- | -2.61 | -- | -3.75 | 29.74 | 32.34 | -18.35 | -3.67 | -- | -0.949 | -- | -- | -5.51 | -12.02 | -624.41 | -- | -- | -- |
| Zenith Drugs Ltd | -100.00bn | -100.00bn | 1.29bn | -- | -- | 5.70 | -- | -- | -- | -- | -- | 13.21 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.8679 | -- | 0.5617 | -- | 24.95 | -- | 64.70 | -- | -- | -- |
| Aarey Drugs and Pharmaceuticals Ltd | 3.48bn | 42.19m | 1.43bn | 0.00 | 30.59 | -- | 24.95 | 0.4098 | 1.66 | 1.66 | 137.72 | -- | -- | -- | -- | -- | -- | 2.78 | -- | 5.84 | 4.17 | 3.66 | 1.21 | 1.52 | -- | 1.63 | -- | -- | -14.96 | 3.70 | -42.38 | -9.40 | 10.95 | -- |
| Sotac Pharmaceuticals Ltd | 579.83m | 44.96m | 1.44bn | 89.00 | 23.32 | 9.09 | 23.48 | 2.48 | 5.58 | 5.58 | 60.69 | 14.31 | -- | -- | -- | -- | -- | -- | -- | -- | 30.90 | -- | 7.75 | -- | 0.9968 | 8.62 | 0.4806 | -- | -20.74 | -- | 56.17 | -- | -- | -- |
| Krebs Biochemicals And Industries Ltd | 499.09m | -208.21m | 1.45bn | 210.00 | -- | -- | -- | 2.90 | -9.50 | -9.50 | 22.86 | -- | -- | -- | -- | 2,376,624.00 | -- | -18.88 | -- | -29.04 | 86.28 | 11.95 | -41.72 | -59.37 | -- | -3.78 | -- | -- | -12.68 | 9.07 | 44.55 | -- | 28.63 | -- |
| Mangalam Drugs and Organics Ltd | 3.57bn | -169.87m | 1.58bn | 523.00 | -- | -- | -- | 0.4419 | -10.74 | -10.74 | 225.21 | -- | -- | -- | -- | 6,834,930.00 | -- | 3.70 | -- | 6.50 | 26.38 | 29.07 | -4.75 | 2.87 | -- | -0.5682 | -- | -- | -17.47 | 5.91 | -93.54 | -42.32 | 11.78 | -- |
| Bal Pharma Ltd | 3.27bn | 35.19m | 1.62bn | -- | 47.35 | -- | 12.01 | 0.4968 | 2.17 | 2.17 | 209.85 | -- | -- | -- | -- | -- | -- | 0.1785 | -- | 0.4782 | 44.02 | 43.81 | 1.08 | 0.1865 | -- | 1.34 | -- | 132.38 | 8.18 | 7.54 | -54.17 | -1.56 | 31.09 | 0.00 |
